Concepedia

Author

Luigi Celio

Fondazione IRCCS Istituto Nazionale dei TumoriORCID

Also Known As

Celio, Luigi, L CELIO, L Celio, L. Celio, Luigi Celio

139

Publications

3.2K

Citations

27

H-Index

55

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei TumoriIstituti di Ricovero e Cura a Carattere ScientificoUniversity of MilanIstituto Tumori BariAzienda Ospedaliera Treviglio
LC

About

Luigi Celio is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

23

707

2

Public Health

2

2

46

3

Biostatistics

2

2

29

4

Cell Biology

2

2

48

5

Health Sciences

1

1

69

Luigi Celio

×

47

Publications

2.4K

Citations

24

H-Index

YearCitations

Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial

Per Eystein Lønning, Emilio Bajetta, Robin Murray,

Journal of Clinical Oncology

2000

318

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Emilio Bajetta, Leonardo Ferrari, Antonia Martinetti,

Cancer

1999

288

Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women

Emilio Bajetta, Giuseppe Procopio, Luigi Celio,

Journal of Clinical Oncology

2005

208

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease.

Emilio Bajetta, Angelo Di Leo, Laura Biganzoli,

Journal of Clinical Oncology

1996

140

Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology Group

Emilio Bajetta, Nicoletta Zilembo, Maria Di Bartolomeo,

Cancer

1993

128

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Jørn Herrstedt, Rebecca Clark-Snow, Christina H. Ruhlmann,

ESMO Open

2024

114

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Emilio Bajetta, L. Ferrari, Giuseppe Procopio,

Annals of Oncology

2002

113

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

Luigi Celio, S. Frustaci, Angela Denaro,

Supportive Care in Cancer

2010

100

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A.1

Emilio Bajetta, Nicoletta Zilembo, Mitch Dowsett,

European Journal of Cancer

1999

69

Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data

Matti Aapro, Florian Scotté, Yolanda Escobar,

The Oncologist

2021

60

Page 1